Literature DB >> 16415096

Pasteurella multocida toxin (PMT) activates RhoGTPases, induces actin polymerization and inhibits migration of human dendritic cells, but does not influence macropinocytosis.

Dagmar Blöcker1, Luciana Berod, Joachim W Fluhr, Joachim Orth, Marco Idzko, Klaus Aktories, Johannes Norgauer.   

Abstract

Dendritic cells (DCs) are considered as one of the principal initiators of immune responses. In their immature state, they migrate into peripheral tissue in order to uptake antigen and to patrol for danger signals. Upon maturation, they acquire the ability to migrate to the lymph nodes and present the captured antigens to T cells in order to direct the development of specific immune responses. There is evidence that microbial compounds interfere with proper functions of DCs in order to block innate and specific immunity. Here we characterized the influence of Pasteurella multocida toxin (PMT) on monocyte-derived DCs. Using pull-down assays with recombinant rhotekin or p21-activated kinase, we demonstrated the activation of RhoGTPases by PMT in DCs. Moreover, PMT induced changes in DC morphology and actin polymerization, impaired chemotaxin-induced actin re-organization and inhibited their migration response. However, macropinocytosis was not influenced by PMT. In summary, these data indicate that PMT inhibits proper function of the motility machinery in DCs, which might limit the development of adaptive immune surveillance during infection with Pasteurella multocida.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16415096     DOI: 10.1093/intimm/dxh386

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  10 in total

1.  Pasteurella multocida toxin-stimulated osteoclast differentiation is B cell dependent.

Authors:  Dagmar Hildebrand; Klaus Heeg; Katharina F Kubatzky
Journal:  Infect Immun       Date:  2010-10-18       Impact factor: 3.441

Review 2.  Cellular and molecular action of the mitogenic protein-deamidating toxin from Pasteurella multocida.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  FEBS J       Date:  2011-05-31       Impact factor: 5.542

3.  YopT domain of the PfhB2 toxin from Pasteurella multocida: protein expression, characterization, crystallization and crystallographic analysis.

Authors:  Sanjeev Kumar; Victoria Hedrick; Seema Mattoo
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2018-02-26       Impact factor: 1.056

Review 4.  Pasteurella multocida: from zoonosis to cellular microbiology.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

Review 5.  Pasteurella multocida toxin interaction with host cells: entry and cellular effects.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

Review 6.  Implications of non-canonical G-protein signaling for the immune system.

Authors:  Cédric Boularan; John H Kehrl
Journal:  Cell Signal       Date:  2014-02-28       Impact factor: 4.315

7.  The actions of Pasteurella multocida toxin on neuronal cells.

Authors:  Susan M Surguy; Denise A Duricki; Joanne M Reilly; Alistair J Lax; Jon Robbins
Journal:  Neuropharmacology       Date:  2013-09-18       Impact factor: 5.250

8.  In Vivo Targets of Pasteurella Multocida Toxin.

Authors:  Arshiya Banu; Alistair J Lax; Agamemnon E Grigoriadis
Journal:  Int J Mol Sci       Date:  2020-04-15       Impact factor: 5.923

9.  The Salmonella SPI2 effector SseI mediates long-term systemic infection by modulating host cell migration.

Authors:  Laura M McLaughlin; Gregory R Govoni; Christiane Gerke; Smita Gopinath; Kaitian Peng; Grace Laidlaw; Yueh-Hsiu Chien; Ha-Won Jeong; Zhigang Li; Matthew D Brown; David B Sacks; Denise Monack
Journal:  PLoS Pathog       Date:  2009-11-26       Impact factor: 6.823

Review 10.  Signaling cascades of Pasteurella multocida toxin in immune evasion.

Authors:  Katharina F Kubatzky; Bianca Kloos; Dagmar Hildebrand
Journal:  Toxins (Basel)       Date:  2013-09-24       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.